BridgeMD
EASE SBS 5 (Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS)
EU CTIS ID: 2024-512486-14-00
What this study is testing
To confirm the efficacy of glepaglutide 10 mg TW in patients with SBS-IF
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- • signed informed consent;
- • age of 18 to 90 years;
- • a diagnosis of SBS, defined as having a small bowel with an estimated length of less than 200 cm (equal to 79 inches) in continuity (latest intestinal resection ≥6 months before screening);
- • stable PS need of ≥3 days per week;
- • no restorative surgery planned during the trial period;
- • having a stoma or colon in continuity
You likely can't join if
- • more than 2 SBS- or PS-related hospitalizations within 6 months before screening;
- • poorly controlled IBD that is moderately or severely active or a fistula that can interfere with the measurements or examinations required in the trial;
- • a history of colorectal cancer or any other type of cancer (except for margin-free resected cutaneous basal, squamous cell carcinoma or adequately treated in situ cervical cancer) unless the patient has been disease-free for at least 5 years; ongoing bowel obstruction;
- • BMI <18.5 kg/m2.
The study team makes the final eligibility decision.
Where it's taking place
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.